News
Summary The best trade show design companies do far more than build booths; they craft experiences. These firms understand ...
Sanofi agrees $2.2bn deal to buy California biotech Inhibrx and its long-acting therapy for rare disease AATD, which causes life-threatening emphysema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results